Mater Misericordiae University Hospital Ltd.

Dublin 7

0 studies enrolling now · 5 studies all time

What they study most

Pulmonary Arterial Hypertension, Pulmonary Hypertension

Studies at this site

• Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) — Completed
• A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients — Completed
• An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients — Completed
• Extension of BPS-MR-PAH-203 in Pulmonary Arterial Hypertension (PAH) Patients — Completed
• FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed